Study of Pembrolizumab (MK-3475) or Placebo With Chemoradiation in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-412/KEYNOTE-412)
Clinical trial NCT03040999 · COMPLETED
Trial details
- NCT number
- NCT03040999
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-05
- Primary completion
- 2022-05-31
- Enrollment
- 804
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.